开云app官网登录入口网页版-官方正版

#急性髓性白血病#

4篇内容 | 2161人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226040, encodeId=517b22260401e, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=30f110e8141b' target=_blank style='color:#2F92EE;'>#吉瑞替尼#</a>, objectTitle=【Leukemia】吉瑞替尼对比挽救化疗治疗亚洲患者为主的R/R FLT3突变AML的3期研究结果, objectType=article, longId=843250, objectId=e5bc84325063, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240904/1725427927213_8538692.jpg, objectUrl=/article/show_article.do?id=e5bc84325063, replyNumber=0, likeNumber=2, createdTime=昨天, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5bc84325063, moduleTitle=【Leukemia】吉瑞替尼对比挽救化疗治疗亚洲患者为主的R/R FLT3突变AML的3期研究结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e5bc84325063)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225528, encodeId=bd542225528d6, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=939b1e68844' target=_blank style='color:#2F92EE;'>#TP53突变#</a>, objectTitle=【Blood】如何改善TP53突变AML的预后？, objectType=article, longId=842803, objectId=f35a842803bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240726/1721988964751_8538692.jpg, objectUrl=/article/show_article.do?id=f35a842803bf, replyNumber=0, likeNumber=8, createdTime=2024-09-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f35a842803bf, moduleTitle=【Blood】如何改善TP53突变AML的预后？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f35a842803bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216440, encodeId=54cd221644006, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=b8156163fe' target=_blank style='color:#2F92EE;'>#DNMT3A突变#</a>, objectTitle=【Am J Cardiol】AML的DNMT3A突变与心衰风险相关, objectType=article, longId=835738, objectId=b1d2835e38ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021813/1628817269945_5549582.jpeg, objectUrl=/article/show_article.do?id=b1d2835e38ee, replyNumber=0, likeNumber=81, createdTime=2024-07-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b1d2835e38ee, moduleTitle=【Am J Cardiol】AML的DNMT3A突变与心衰风险相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b1d2835e38ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215601, encodeId=ffad2215601fe, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=e56199944e0' target=_blank style='color:#2F92EE;'>#靶向药物#</a> <a href='/topic/show?id=a2ae3e9175e' target=_blank style='color:#2F92EE;'>#发病机制#</a> <a href='/topic/show?id=dc35116802d4' target=_blank style='color:#2F92EE;'>#分化综合征#</a>, objectTitle=【Blood】How I Treat：分化综合征的诊断和治疗, objectType=article, longId=835110, objectId=106f835110bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240717/1721178253498_8538692.jpg, objectUrl=/article/show_article.do?id=106f835110bf, replyNumber=0, likeNumber=113, createdTime=2024-07-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=106f835110bf, moduleTitle=【Blood】How I Treat：分化综合征的诊断和治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=106f835110bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215210, encodeId=24ff221521098, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=54a4116e389f' target=_blank style='color:#2F92EE;'>#KMT2A重排#</a>, objectTitle=【Leukemia】KMT2A重排成人AML的突变特征和预后, objectType=article, longId=834636, objectId=5799834636ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021813/1628817269945_5549582.jpeg, objectUrl=/article/show_article.do?id=5799834636ee, replyNumber=0, likeNumber=78, createdTime=2024-07-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5799834636ee, moduleTitle=【Leukemia】KMT2A重排成人AML的突变特征和预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5799834636ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215041, encodeId=a3552215041e7, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=16339188493' target=_blank style='color:#2F92EE;'>#诱导治疗#</a> <a href='/topic/show?id=a889116665d6' target=_blank style='color:#2F92EE;'>#D14骨髓活检#</a>, objectTitle=【AJH】诱导治疗后第14天骨髓活检在AML的预测价值受到质疑, objectType=article, longId=834652, objectId=dce483465260, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719493092261_2570354.jpg, objectUrl=/article/show_article.do?id=dce483465260, replyNumber=0, likeNumber=95, createdTime=2024-07-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dce483465260, moduleTitle=【AJH】诱导治疗后第14天骨髓活检在AML的预测价值受到质疑, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dce483465260)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213912, encodeId=97d02213912c4, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=afa4384e30e' target=_blank style='color:#2F92EE;'>#可测量残留病#</a>, objectTitle=【Leukemia】流式MRD监测可抢先检测高危AML的MRD复发, objectType=article, longId=833493, objectId=674383349352, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240708/1720405372082_1608702.jpg, objectUrl=/article/show_article.do?id=674383349352, replyNumber=0, likeNumber=80, createdTime=2024-07-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=674383349352, moduleTitle=【Leukemia】流式MRD监测可抢先检测高危AML的MRD复发, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=674383349352)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211343, encodeId=433122113435b, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a> <a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=30f110e8141b' target=_blank style='color:#2F92EE;'>#吉瑞替尼#</a>, objectTitle=JCI：新研究表明化合物HSN748有望治疗耐药性急性髓性白血病, objectType=article, longId=831524, objectId=08538315248d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240623/1719142901618_2185383.png, objectUrl=/article/show_article.do?id=08538315248d, replyNumber=0, likeNumber=49, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211005, encodeId=c6f9221100557, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=c52225680c6' target=_blank style='color:#2F92EE;'>#伊马替尼#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a>, objectTitle=【BCJ】伊马替尼联合强烈化疗治疗BCR::ABL1+ AML的预后较好, objectType=article, longId=831185, objectId=877883118514, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240621/1718953300480_5579292.jpg, objectUrl=/article/show_article.do?id=877883118514, replyNumber=0, likeNumber=74, createdTime=2024-06-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=877883118514, moduleTitle=【BCJ】伊马替尼联合强烈化疗治疗BCR::ABL1+ AML的预后较好, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=877883118514)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210228, encodeId=5d87221022807, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=62e7115581a6' target=_blank style='color:#2F92EE;'>#非亲缘移植#</a>, objectTitle=【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异, objectType=article, longId=830351, objectId=87c483035125, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240616/1718550177829_5579292.jpg, objectUrl=/article/show_article.do?id=87c483035125, replyNumber=0, likeNumber=72, createdTime=2024-06-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=87c483035125, moduleTitle=【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=87c483035125)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209768, encodeId=55192209e68a8, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=ae97180090b' target=_blank style='color:#2F92EE;'>#T细胞#</a> <a href='/topic/show?id=c0a811549083' target=_blank style='color:#2F92EE;'>#ICAM1#</a>, objectTitle=Leukemia：ICAM1在T细胞杀伤急髓白血病中的关键作用, objectType=article, longId=828149, objectId=1769828149e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240613/1718267349913_5579292.jpg, objectUrl=/article/show_article.do?id=1769828149e9, replyNumber=0, likeNumber=86, createdTime=2024-06-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1769828149e9, moduleTitle=Leukemia：ICAM1在T细胞杀伤急髓白血病中的关键作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1769828149e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207643, encodeId=7d09220e643e0, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=fb8c101948e6' target=_blank style='color:#2F92EE;'>#骨髓#</a> <a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, objectTitle=AJH：外周血对比骨髓：≥60岁AML CR期减低强度预处理单倍型移植的移植物选择, objectType=article, longId=828146, objectId=9c6c828146e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240531/1717125219441_1608702.jpg, objectUrl=/article/show_article.do?id=9c6c828146e4, replyNumber=0, likeNumber=78, createdTime=2024-05-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9c6c828146e4, moduleTitle=AJH：外周血对比骨髓：≥60岁AML CR期减低强度预处理单倍型移植的移植物选择, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9c6c828146e4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205060, encodeId=73c9220506047, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=6901114539b8' target=_blank style='color:#2F92EE;'>#残留病灶#</a>, objectTitle=【JAMA Oncol】FLT3-ITD AML异基因移植前MRD与结局相关，尤其是VAF≥0.01%, objectType=article, longId=825916, objectId=41ca825916e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240516/1715849003911_5579292.jpg, objectUrl=/article/show_article.do?id=41ca825916e9, replyNumber=0, likeNumber=80, createdTime=2024-05-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=41ca825916e9, moduleTitle=【JAMA Oncol】FLT3-ITD AML异基因移植前MRD与结局相关，尤其是VAF≥0.01%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=41ca825916e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205071, encodeId=a5fd22050e128, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=94a511454103' target=_blank style='color:#2F92EE;'>#FBL#</a>, objectTitle=NCB：浙江大学钱鹏旭/黄河发现相分离诱导的FBL促进急性髓性白血病早期pre-rRNA加工和翻译, objectType=article, longId=826100, objectId=306082610089, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240516/1715848553289_5579292.png, objectUrl=/article/show_article.do?id=306082610089, replyNumber=0, likeNumber=80, createdTime=2024-05-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=306082610089, moduleTitle=NCB：浙江大学钱鹏旭/黄河发现相分离诱导的FBL促进急性髓性白血病早期pre-rRNA加工和翻译, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=306082610089)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204636, encodeId=546a220463627, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=dde9114454c6' target=_blank style='color:#2F92EE;'>#NPM1突变#</a>, objectTitle=Blood：1357例NPM1突变AML的分子学、临床特征、治疗及其对结局的影响, objectType=article, longId=825780, objectId=dea2825e8053, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240514/1715671778594_5579292.jpg, objectUrl=/article/show_article.do?id=dea2825e8053, replyNumber=0, likeNumber=104, createdTime=2024-05-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dea2825e8053, moduleTitle=Blood：1357例NPM1突变AML的分子学、临床特征、治疗及其对结局的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dea2825e8053)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204429, encodeId=172c220442919, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=e61e1144049f' target=_blank style='color:#2F92EE;'>#遗传动力学#</a>, objectTitle=Haematologica：急性髓系白血病首次复发的结局和遗传动力学, objectType=article, longId=825641, objectId=c2f6825641d9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240513/1715579180049_5579292.jpg, objectUrl=/article/show_article.do?id=c2f6825641d9, replyNumber=0, likeNumber=88, createdTime=2024-05-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c2f6825641d9, moduleTitle=Haematologica：急性髓系白血病首次复发的结局和遗传动力学, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c2f6825641d9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182573, encodeId=b60921825e3c3, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=9bd19050a2' target=_blank style='color:#2F92EE;'>#HoxA9#</a> <a href='/topic/show?id=3bec151e616' target=_blank style='color:#2F92EE;'>#RBM5#</a>, objectTitle=Genome Biol：揭示蛋白RBM5通过激活致癌蛋白HOXA9在急性髓系白血病中发挥重要作用, objectType=article, longId=809443, objectId=5f42809443ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240114/1705228123941_2185383.png, objectUrl=/article/show_article.do?id=5f42809443ee, replyNumber=0, likeNumber=76, createdTime=2024-01-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182019, encodeId=abc6218201997, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=9c363e259ba' target=_blank style='color:#2F92EE;'>#去甲基化#</a> <a href='/topic/show?id=e50811014034' target=_blank style='color:#2F92EE;'>#维奈克拉#</a>, objectTitle=【JIM】遗传学特征可预测维奈克拉联合去甲基化药物治疗R/R AML的疗效, objectType=article, longId=809497, objectId=d52580949eb0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=d52580949eb0, replyNumber=0, likeNumber=93, createdTime=2024-01-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=d52580949eb0, moduleTitle=【JIM】遗传学特征可预测维奈克拉联合去甲基化药物治疗R/R AML的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d52580949eb0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2169022, encodeId=12ed2169022a4, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> 对于老年急性髓性白血病（AML）患者（年龄≥60岁的患者），异基因造血干细胞移植 (HSCT)实现了重大生存改善，但宿主因素和白血病因素可能导致患者不适合蒽环类药物或以阿糖胞苷为基础的标准缓解诱导化疗（称为3+7方案）。此外对于接受3+7的老年患者，该方案是否是异基因 HSCT 前的最佳治疗也受到质疑，因为在大型临床试验中适合接受强化化疗的老年AML患者中，只有1/3最终实现HSCT。因此，迫切需要有效但耐受性更好的治疗策略来提高老年AML患者的异基因HSCT 率。, objectTitle=急性髓性白血病, objectType=topic, longId=52479, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=79, createdTime=2023-11-17, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2169008, encodeId=c899216900878, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=2d4c4140296' target=_blank style='color:#2F92EE;'>#地西他滨#</a>, objectTitle=Lancet Haematol：地西他滨10天方案对比3+7治疗老年AML的3期研究, objectType=article, longId=800951, objectId=eebb80095160, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=eebb80095160, replyNumber=0, likeNumber=95, createdTime=2023-11-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=eebb80095160, moduleTitle=Lancet Haematol：地西他滨10天方案对比3+7治疗老年AML的3期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eebb80095160)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 风湿免疫小助手

急性髓性白血病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #吉瑞替尼#

【Leukemia】吉瑞替尼对比挽救化疗治疗亚洲患者为主的R/R FLT3突变AML的3期研究结果

昨天发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #TP53突变#

【Blood】如何改善TP53突变AML的预后？

2024-09-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #DNMT3A突变#

【Am J Cardiol】AML的DNMT3A突变与心衰风险相关

2024-07-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #靶向药物# #发病机制# #分化综合征#

【Blood】How I Treat：分化综合征的诊断和治疗

2024-07-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #KMT2A重排#

【Leukemia】KMT2A重排成人AML的突变特征和预后

2024-07-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #诱导治疗# #D14骨髓活检#

【AJH】诱导治疗后第14天骨髓活检在AML的预测价值受到质疑

2024-07-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #可测量残留病#

【Leukemia】流式MRD监测可抢先检测高危AML的MRD复发

2024-07-08发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#FLT3# #急性髓性白血病# #吉瑞替尼#

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #伊马替尼# #AML#

【BCJ】伊马替尼联合强烈化疗治疗BCR::ABL1+ AML的预后较好

2024-06-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #GVHD# #非亲缘移植#

【AJH】AML非亲缘移植，PTCy与传统GVHD预防的复发率无差异

2024-06-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #T细胞# #ICAM1#

Leukemia：ICAM1在T细胞杀伤急髓白血病中的关键作用

2024-06-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #骨髓# #外周血#

AJH：外周血对比骨髓：≥60岁AML CR期减低强度预处理单倍型移植的移植物选择

2024-05-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #残留病灶#

【JAMA Oncol】FLT3-ITD AML异基因移植前MRD与结局相关，尤其是VAF≥0.01%

2024-05-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #FBL#

NCB：浙江大学钱鹏旭/黄河发现相分离诱导的FBL促进急性髓性白血病早期pre-rRNA加工和翻译

2024-05-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #NPM1突变#

Blood：1357例NPM1突变AML的分子学、临床特征、治疗及其对结局的影响

2024-05-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #遗传动力学#

Haematologica：急性髓系白血病首次复发的结局和遗传动力学

2024-05-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #HoxA9# #RBM5#

2024-01-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #去甲基化# #维奈克拉#

【JIM】遗传学特征可预测维奈克拉联合去甲基化药物治疗R/R AML的疗效

2024-01-16发表于陕西省

yangchou (审核中...)

前往app查看评论内容

全文收起 #急性髓性白血病# 对于老年急性髓性白血病（AML）患者（年龄≥60岁的患者），异基因造血干细胞移植 (HSCT)实现了重大生存改善，但宿主因素和白血病因素可能导致患者不适合蒽环类药物或以阿糖胞苷为基础的标准缓解诱导化疗（称为3+7方案）。此外对于接受3+7的老年患者，该方案是否是异基因 HSCT 前的最佳治疗也受到质疑，因为在大型临床试验中适合接受强化化疗的老年AML患者中，只有1/3最终实现HSCT。因此，迫切需要有效但耐受性更好的治疗策略来提高老年AML患者的异基因HSCT 率。

2023-11-17发表于浙江省

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #地西他滨#

Lancet Haematol：地西他滨10天方案对比3+7治疗老年AML的3期研究

2023-11-17发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务